Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Natco Pharma

Sector: Healthcare | Industry: Drugs & Pharma
R 594.25 7.05  | 1.20% -16.41% 19.92 10,805.02
NSE Price: Dec 06, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Dec 06, 15:59 594.25 7.05 1.20% 586.50 587.20 189,244 586.50 - 602.00
BSE Dec 06, 2019 594.05 6.60 1.12% 590.10 587.45 3,290 590.10 - 601.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 206,012 P/B: 2.93 NSE Code: NATCOPHARM
52-Week Range: R 480.00 - 717.90 Dividend Yield: 1.05% BSE Code: 524816
TTM EPS: R 29.83 Book Value: R 202.60 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Lupin (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 37 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Natco Pharma -12.62 2.26 5.30 -16.41 -0.13 15.00 38.09
S&P BSE Mid Cap* -3.78 0.89 11.83 -0.39 6.55 7.19 8.44
S&P BSE Healthcare* -3.24 2.16 4.31 -2.91 -4.93 -2.03 10.33
Company's return has been calculated on basis of NSE's price.
As on Dec 06, 2019
*As on Dec 05, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -4.13 22.43 23.17
Net Profit -7.59 60.35 45.62
EPS -6.43 57.55 41.55
Book Value 14.69 36.87 33.98
Average
Operating Margin 44.16 41.01 35.09
Net Margin 28.88 27.99 22.60
Return on Networth 19.75 27.55 22.77
Return on Investment 23.71 32.73 26.37
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -1.34 -10.63 6.58
Operating Profit -21.10 -35.70 -6.58
Net Profit -17.58 -35.19 -2.24
EPS -16.90 -33.90 -1.22
TTM
Revenue -2.82 -17.48 -4.97
Operating Profit -10.52 -34.93 -14.51
Net Profit -10.58 -38.60 -15.91
EPS -10.15 -37.85 -15.21
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Natco Pharma 10,805.02 1,990.40 540.20 25.74 19.75 2.93 19.92
Lupin 34,539.22 17,689.22 318.63 1.77 4.55 2.54 110.07
Piramal Enterprises 32,677.45 14,278.56 1,708.87 11.71 4.28 1.23 15.81
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jun 29, 2019 V C NANNAPANENI  Sell Inter-Se Transfer 12,723,340 534.90 68,057.15
Jun 29, 2019 V C NANNAPANENI  Sell Inter-Se Transfer 12,723,340 534.90 68,057.15
Jun 29, 2019 VENKATA SATYA SWATHI KANTAMANI  Buy Inter-Se Transfer 12,723,340 534.90 68,057.15
Jun 29, 2019 VENKATA SATYA SWATHI KANTAMANI  Buy Inter-Se Transfer 12,723,340 534.90 68,057.15
Feb 18, 2019 POTLURI SIVARAMAKRISHNA PRASAD  Buy Market 1,500 575.15 8.63
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Aditya Birla Sun Life Mutual Fund 2.466 2.398 2.505 2.787 2.738
Franklin Templeton Mutual Fund 1.429 1.264 1.260 - -
Mirae Asset Mutual Fund 1.213 1.198 0.344 0.272 0.144
Sundaram Mutual Fund 0.741 0.682 0.596 0.441 0.440
ICICI Prudential Mutual Fund 0.585 0.368 0.202 0.102 0.102
Principal Mutual Fund 0.208 0.198 0.166 0.152 0.147
IDFC Mutual Fund 0.167 0.272 0.491 0.680 0.756
Tata Mutual Fund 0.166 0.166 0.165 0.164 0.184
UTI Mutual Fund 0.160 0.117 0.033 - -
SBI Mutual Fund 0.107 0.107 0.107 0.398 0.473
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Natco Pharma Ltd.

Address: Natco House, Road No 2, Banjara Hills, Hyderabad, Telangana - 500003 | Phone: 040-23547532 | Fax: 040-23548243

Email: [email protected] / [email protected]

Website: www.natcopharma.co.in

Registrar & Transfer Agent: Venture Capital & Corporate Investments Ltd

Address: 12-10-167, MIG- 167,Bharat Nagar Colony,Hyderabad – 500018.Phone: +91-40-23818475/6Fax : +91-40-23868024Email: [email protected], 12-10-167,, MIG- 167,, Bharat Nagar Colony | Phone: 91-40-23818475/6 | Fax: 91-40-23868024

Email: [email protected]

Essential checks
Altman Z-Score
10.55
Piotroski F-Score
4
Modified C-Score
2
5-Years Price to Earnings
19.92
5-Years Price to Book
2.93
Earnings Yield
EBIT / Enterprise value
6.55%
PEG
Price / Earnings to growth ratio
0.55
Related Stocks
  Current Price   Chng %
Abbott India R12,801.30 +0.23%
Alkem Laboratories R2,079.35 -0.58%
Aurobindo Pharma R445.70 -0.77%
Biocon R289.00 +0.84%
Cadila Healthcare R255.30 -0.91%
Glaxosmithkline Pharma R1,635.90 -0.77%
Lupin R761.85 -2.28%
Pfizer R4,311.15 +0.07%
Piramal Enterprises R1,644.10 -3.66%
Torrent Pharmaceuticals R1,851.45 -1.20%
As on Dec 06, 15:59